Next Generation Diabetes Therapy and Drug Delivery Market by Product Type (Inhalable Insulin, Oral Insulin, Insulin Patches, CGM Systems, Artificial Pancreas), Demographic (Adult Population (>14 Years), Child Population (14 Years)), Indication (Type 1 diabetes, Type 2 diabetes), End User (Diagnostic/Clinics, Intensive Care Units (ICUs), Home Healthcare), and Region 2024-2032
The global next generation diabetes therapy and drug delivery market size reached US$ 9.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.5 Billion by 2032, exhibiting a growth rate (CAGR) of 14.23% during 2024-2032. The rising prevalence of diabetes, particularly type-2 diabetes, continual technological advancements, and the growing geriatric population represent some of the key factors driving the market.
Next generation diabetes therapy and drug delivery procedure focuses on the introduction of insulin into the patient’s body in a minimally invasive manner to reduce the risk of skin irritation from frequent needle usage. This patient-friendly approach aims to effectively manage the disease while reducing healthcare costs by utilizing innovative technologies including wearable sensors, micro-needles, and inhalable insulin. Advanced therapies, such as continuous glucose monitoring systems (CGMS), artificial pancreas, and insulin patches, are also employed to improve blood sugar level management that minimize the risks of diabetic-related complications. In addition, the procedure facilitates easy calculation of the dose volume, checking the blood glucose levels in real-time, and delivers insulin into the body painlessly, which, in turn, helps to maintain the dosage time. Some of the advantages of this therapy and drug delivery practice includes improved patient outcomes, enhanced treatment efficiency, and minimized burden of diabetes management for patients, leading to more targeted treatment plans.
Next Generation Diabetes Therapy and Drug Delivery Market Trends:
The global market is primarily driven by the rising prevalence of diabetes, particularly type-2 diabetes, among the masses. This can be attributed to the increasing consumption of unhealthy diets, sedentary lifestyles and reduced physical activity. In line with this, the augmenting demand for personalized and patient-centric care according to individual needs, lifestyle, and treatment goals is resulting in a higher product uptake. Moreover, continual technological advancements, such as the development of smart insulin pens, closed-loop systems, and implantable devices with fewer side effects, is providing an impetus to the market. In addition to this, the increasing emphasis on minimally invasive and pain-free treatment options among individuals is also acting as a significant growth-inducing factor for the market. The market is further driven by the increasing healthcare expenditure, along with an enhanced focus on value-based medical care solutions. However, the growing cost restrains, lack of awareness and less variability in products in the developing regions are acting as major growth-restraining factors for the market. Conversely, the implementation of favorable government initiatives and reimbursement policies regarding preventive healthcare and early intervention is creating a positive outlook for the market. Apart from this, the growing geriatric population that is more susceptible to developing chronic diseases is impacting the market favorably. Some of the other factors contributing to the market include rapid urbanization, increasing awareness regarding the associated complications of traditional diabetes treatment, rising adoption of telehealth and digital health solutions, inflating disposable income levels and extensive research and development (R&D) activities conducted by key players.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global next generation diabetes therapy and drug delivery market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, demographic, indication, and end user.
Product Type Insights:
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
The report has provided a detailed breakup and analysis of the global next generation diabetes therapy and drug delivery market based on the product type. This includes inhalable insulin, oral insulin, insulin patches, CGM systems, and artificial pancreas. According to the report, CGM systems represented the largest segment.
Demographic Insights:
Adult Population (>14 Years)
Child Population (14 Years)
The report has provided a detailed breakup and analysis of the global next generation diabetes therapy and drug delivery market based on the demographic. This includes adult population (>14 years) and child population (14 years). According to the report, adult population (>14 years) represented the largest segment.
Indication Insights:
Type 1 diabetes
Type 2 diabetes
The report has provided a detailed breakup and analysis of the global next generation diabetes therapy and drug delivery market based on the indication. This includes type 1 diabetes, type 2 diabetes. According to the report, type 2 diabetes represented the largest segment.
End User Insights:
Diagnostic/Clinics
Intensive Care Units (ICUs)
Home Healthcare
A detailed breakup and analysis of the global next generation diabetes therapy and drug delivery market based on the end user has also been provided in the report. This includes diagnostic/clinics, intensive care units (ICUs), and home healthcare. According to the report, diagnostic/clinics accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for next generation diabetes therapy and drug delivery. Some of the factors driving the North America next generation diabetes therapy and drug delivery market included the aging population, continual technological advancements, high healthcare expenditure, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global next generation diabetes therapy and drug delivery market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Dexcom Inc., Eli Lilly and Company, Enteris BioPharma Inc. (Swk Holdings Corporation), GlySens Incorporated, MannKind Corporation, Medtronic plc, Sanofi, Senseonics, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global next generation diabetes therapy and drug delivery market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global next generation diabetes therapy and drug delivery market?
What is the impact of each driver, restraint, and opportunity on the global next generation diabetes therapy and drug delivery market?
What are the key regional markets?
Which countries represent the most attractive global next generation diabetes therapy and drug delivery market?
What is the breakup of the market based on the product type?
Which is the most attractive product type in the global next generation diabetes therapy and drug delivery market?
What is the breakup of the market based on the demographic?
Which is the most attractive demographic in the global next generation diabetes therapy and drug delivery market?
What is the breakup of the market based on the indication?
Which is the most attractive indication in the global next generation diabetes therapy and drug delivery market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the global next generation diabetes therapy and drug delivery market?
What is the competitive structure of the global next generation diabetes therapy and drug delivery market?
Who are the key players/companies in the global next generation diabetes therapy and drug delivery market?
Next generation diabetes therapy and drug delivery procedure focuses on the introduction of insulin into the patient’s body in a minimally invasive manner to reduce the risk of skin irritation from frequent needle usage. This patient-friendly approach aims to effectively manage the disease while reducing healthcare costs by utilizing innovative technologies including wearable sensors, micro-needles, and inhalable insulin. Advanced therapies, such as continuous glucose monitoring systems (CGMS), artificial pancreas, and insulin patches, are also employed to improve blood sugar level management that minimize the risks of diabetic-related complications. In addition, the procedure facilitates easy calculation of the dose volume, checking the blood glucose levels in real-time, and delivers insulin into the body painlessly, which, in turn, helps to maintain the dosage time. Some of the advantages of this therapy and drug delivery practice includes improved patient outcomes, enhanced treatment efficiency, and minimized burden of diabetes management for patients, leading to more targeted treatment plans.
Next Generation Diabetes Therapy and Drug Delivery Market Trends:
The global market is primarily driven by the rising prevalence of diabetes, particularly type-2 diabetes, among the masses. This can be attributed to the increasing consumption of unhealthy diets, sedentary lifestyles and reduced physical activity. In line with this, the augmenting demand for personalized and patient-centric care according to individual needs, lifestyle, and treatment goals is resulting in a higher product uptake. Moreover, continual technological advancements, such as the development of smart insulin pens, closed-loop systems, and implantable devices with fewer side effects, is providing an impetus to the market. In addition to this, the increasing emphasis on minimally invasive and pain-free treatment options among individuals is also acting as a significant growth-inducing factor for the market. The market is further driven by the increasing healthcare expenditure, along with an enhanced focus on value-based medical care solutions. However, the growing cost restrains, lack of awareness and less variability in products in the developing regions are acting as major growth-restraining factors for the market. Conversely, the implementation of favorable government initiatives and reimbursement policies regarding preventive healthcare and early intervention is creating a positive outlook for the market. Apart from this, the growing geriatric population that is more susceptible to developing chronic diseases is impacting the market favorably. Some of the other factors contributing to the market include rapid urbanization, increasing awareness regarding the associated complications of traditional diabetes treatment, rising adoption of telehealth and digital health solutions, inflating disposable income levels and extensive research and development (R&D) activities conducted by key players.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global next generation diabetes therapy and drug delivery market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, demographic, indication, and end user.
Product Type Insights:
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
The report has provided a detailed breakup and analysis of the global next generation diabetes therapy and drug delivery market based on the product type. This includes inhalable insulin, oral insulin, insulin patches, CGM systems, and artificial pancreas. According to the report, CGM systems represented the largest segment.
Demographic Insights:
Adult Population (>14 Years)
Child Population (14 Years)
The report has provided a detailed breakup and analysis of the global next generation diabetes therapy and drug delivery market based on the demographic. This includes adult population (>14 years) and child population (14 years). According to the report, adult population (>14 years) represented the largest segment.
Indication Insights:
Type 1 diabetes
Type 2 diabetes
The report has provided a detailed breakup and analysis of the global next generation diabetes therapy and drug delivery market based on the indication. This includes type 1 diabetes, type 2 diabetes. According to the report, type 2 diabetes represented the largest segment.
End User Insights:
Diagnostic/Clinics
Intensive Care Units (ICUs)
Home Healthcare
A detailed breakup and analysis of the global next generation diabetes therapy and drug delivery market based on the end user has also been provided in the report. This includes diagnostic/clinics, intensive care units (ICUs), and home healthcare. According to the report, diagnostic/clinics accounted for the largest market share.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for next generation diabetes therapy and drug delivery. Some of the factors driving the North America next generation diabetes therapy and drug delivery market included the aging population, continual technological advancements, high healthcare expenditure, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global next generation diabetes therapy and drug delivery market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Dexcom Inc., Eli Lilly and Company, Enteris BioPharma Inc. (Swk Holdings Corporation), GlySens Incorporated, MannKind Corporation, Medtronic plc, Sanofi, Senseonics, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
How has the global next generation diabetes therapy and drug delivery market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global next generation diabetes therapy and drug delivery market?
What is the impact of each driver, restraint, and opportunity on the global next generation diabetes therapy and drug delivery market?
What are the key regional markets?
Which countries represent the most attractive global next generation diabetes therapy and drug delivery market?
What is the breakup of the market based on the product type?
Which is the most attractive product type in the global next generation diabetes therapy and drug delivery market?
What is the breakup of the market based on the demographic?
Which is the most attractive demographic in the global next generation diabetes therapy and drug delivery market?
What is the breakup of the market based on the indication?
Which is the most attractive indication in the global next generation diabetes therapy and drug delivery market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the global next generation diabetes therapy and drug delivery market?
What is the competitive structure of the global next generation diabetes therapy and drug delivery market?
Who are the key players/companies in the global next generation diabetes therapy and drug delivery market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT TYPE
6.1 Inhalable Insulin
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Oral Insulin
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Insulin Patches
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 CGM Systems
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Artificial Pancreas
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY DEMOGRAPHIC
7.1 Adult Population (>14 Years)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Child Population (14 Years)
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY INDICATION
8.1 Type 1 Diabetes
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Type 2 Diabetes
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Diagnostic/Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Intensive Care Units (ICUs)
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Home Healthcare
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 DRIVERS, RESTRAINTS, AND OPPORTUNITIES
11.1 Overview
11.2 Drivers
11.3 Restraints
11.4 Opportunities
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Dexcom Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Eli Lilly and Company
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Enteris BioPharma Inc. (Swk Holdings Corporation)
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 GlySens Incorporated
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 MannKind Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Medtronic plc
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Sanofi
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Senseonics
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT TYPE
6.1 Inhalable Insulin
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Oral Insulin
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Insulin Patches
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 CGM Systems
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Artificial Pancreas
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY DEMOGRAPHIC
7.1 Adult Population (>14 Years)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Child Population (14 Years)
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY INDICATION
8.1 Type 1 Diabetes
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Type 2 Diabetes
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Diagnostic/Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Intensive Care Units (ICUs)
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Home Healthcare
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 DRIVERS, RESTRAINTS, AND OPPORTUNITIES
11.1 Overview
11.2 Drivers
11.3 Restraints
11.4 Opportunities
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Dexcom Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Eli Lilly and Company
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Enteris BioPharma Inc. (Swk Holdings Corporation)
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 GlySens Incorporated
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 MannKind Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Medtronic plc
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Sanofi
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Senseonics
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
LIST OF TABLES
Table 1: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 3: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Demographic (in Million US$), 2024-2032
Table 4: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 5: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Competitive Structure
Table 8: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Key Players
Table 1: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 3: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Demographic (in Million US$), 2024-2032
Table 4: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 5: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Competitive Structure
Table 8: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Key Players
LIST OF FIGURES
Figure 1: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Major Drivers and Challenges
Figure 2: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Product Type (in %), 2023
Figure 5: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Demographic (in %), 2023
Figure 6: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Indication (in %), 2023
Figure 7: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by End User (in %), 2023
Figure 8: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Region (in %), 2023
Figure 9: Global: Next Generation Diabetes Therapy and Drug Delivery (Inhalable Insulin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Next Generation Diabetes Therapy and Drug Delivery (Inhalable Insulin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Next Generation Diabetes Therapy and Drug Delivery (Oral Insulin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Next Generation Diabetes Therapy and Drug Delivery (Oral Insulin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Next Generation Diabetes Therapy and Drug Delivery (Insulin Patches) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Next Generation Diabetes Therapy and Drug Delivery (Insulin Patches) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Next Generation Diabetes Therapy and Drug Delivery (CGM Systems) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Next Generation Diabetes Therapy and Drug Delivery (CGM Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Next Generation Diabetes Therapy and Drug Delivery (Artificial Pancreas) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Next Generation Diabetes Therapy and Drug Delivery (Artificial Pancreas) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Next Generation Diabetes Therapy and Drug Delivery (Adult Population (>14 Years)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Next Generation Diabetes Therapy and Drug Delivery (Adult Population (>14 Years)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Next Generation Diabetes Therapy and Drug Delivery (Child Population (14 Years)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Next Generation Diabetes Therapy and Drug Delivery (Child Population (14 Years)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 1 Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 1 Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 2 Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 2 Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Next Generation Diabetes Therapy and Drug Delivery (Diagnostic/Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Next Generation Diabetes Therapy and Drug Delivery (Diagnostic/Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Next Generation Diabetes Therapy and Drug Delivery (Intensive Care Units (ICUs)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Next Generation Diabetes Therapy and Drug Delivery (Intensive Care Units (ICUs)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Next Generation Diabetes Therapy and Drug Delivery (Home Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Next Generation Diabetes Therapy and Drug Delivery (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: North America: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: North America: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: United States: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: United States: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Canada: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Canada: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Asia-Pacific: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Asia-Pacific: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: China: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: China: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Japan: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Japan: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: India: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: India: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: South Korea: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: South Korea: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Australia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Australia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Indonesia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Indonesia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Europe: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Europe: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Germany: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Germany: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: France: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: France: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: United Kingdom: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: United Kingdom: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Italy: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Italy: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Spain: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Spain: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Russia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Russia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Latin America: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Latin America: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Brazil: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Brazil: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Mexico: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Mexico: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Country (in %), 2023
Figure 81: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Drivers, Restraints, and Opportunities
Figure 83: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Value Chain Analysis
Figure 84: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Porter's Five Forces Analysis
Figure 1: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Major Drivers and Challenges
Figure 2: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Product Type (in %), 2023
Figure 5: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Demographic (in %), 2023
Figure 6: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Indication (in %), 2023
Figure 7: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by End User (in %), 2023
Figure 8: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Region (in %), 2023
Figure 9: Global: Next Generation Diabetes Therapy and Drug Delivery (Inhalable Insulin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Next Generation Diabetes Therapy and Drug Delivery (Inhalable Insulin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Next Generation Diabetes Therapy and Drug Delivery (Oral Insulin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Next Generation Diabetes Therapy and Drug Delivery (Oral Insulin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Next Generation Diabetes Therapy and Drug Delivery (Insulin Patches) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Next Generation Diabetes Therapy and Drug Delivery (Insulin Patches) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Next Generation Diabetes Therapy and Drug Delivery (CGM Systems) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Next Generation Diabetes Therapy and Drug Delivery (CGM Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Next Generation Diabetes Therapy and Drug Delivery (Artificial Pancreas) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Next Generation Diabetes Therapy and Drug Delivery (Artificial Pancreas) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Next Generation Diabetes Therapy and Drug Delivery (Adult Population (>14 Years)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Next Generation Diabetes Therapy and Drug Delivery (Adult Population (>14 Years)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Next Generation Diabetes Therapy and Drug Delivery (Child Population (14 Years)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Next Generation Diabetes Therapy and Drug Delivery (Child Population (14 Years)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 1 Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 1 Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 2 Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 2 Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Next Generation Diabetes Therapy and Drug Delivery (Diagnostic/Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Next Generation Diabetes Therapy and Drug Delivery (Diagnostic/Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Next Generation Diabetes Therapy and Drug Delivery (Intensive Care Units (ICUs)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Next Generation Diabetes Therapy and Drug Delivery (Intensive Care Units (ICUs)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Next Generation Diabetes Therapy and Drug Delivery (Home Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Next Generation Diabetes Therapy and Drug Delivery (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: North America: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: North America: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: United States: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: United States: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Canada: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Canada: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Asia-Pacific: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Asia-Pacific: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: China: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: China: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Japan: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Japan: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: India: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: India: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: South Korea: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: South Korea: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Australia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Australia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Indonesia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Indonesia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Europe: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Europe: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Germany: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Germany: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: France: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: France: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: United Kingdom: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: United Kingdom: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Italy: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Italy: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Spain: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Spain: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Russia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Russia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Latin America: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Latin America: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Brazil: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Brazil: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Mexico: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Mexico: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Country (in %), 2023
Figure 81: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Drivers, Restraints, and Opportunities
Figure 83: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Value Chain Analysis
Figure 84: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Porter's Five Forces Analysis
